Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 10 descriptions
No. | Drug (Description in trials) | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acylated and unacylated ghrelin dosages | [1] Lenomorelin Lenomorelin | - | - | - | [3] 193 193, 201, 202 💬
| ||||||||||||||||||||||||||||||
2 | CC | - | - | - | - | [13] 28 28, 46, 49, 51, 56, 84, 85, 96, 97, 98, 162, 202, 271 💬2. CC
| ||||||||||||||||||||||||||||||
3 | DTR Melatonin (NIH CC PDS) | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬3. DTR Melatonin (NIH CC PDS)
| [2] MTNR1A MTNR1A,MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 202 202 💬3. DTR Melatonin (NIH CC PDS)
| ||||||||||||||||||||||||||||||
4 | Ghrelin | [1] Lenomorelin Lenomorelin | - | - | - | [6] 6 6, 78, 193, 201, 202, 299 💬
| ||||||||||||||||||||||||||||||
5 | Hourly dosing of the nychtemeral secretion of melatonin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬5. Hourly dosing of the nychtemeral secretion of melatonin
| [2] MTNR1A MTNR1A,MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 202 202 💬5. Hourly dosing of the nychtemeral secretion of melatonin
| ||||||||||||||||||||||||||||||
6 | Melatonin | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬6. Melatonin
| [2] MTNR1A MTNR1A,MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [12] 6 6, 8, 13, 37, 46, 49, 72, 78, 90, 97, 145, 202 💬6. Melatonin
| ||||||||||||||||||||||||||||||
7 | Melatonin CR | [1] Melatonin Melatonin | [1] Melatonin
Melatonin
💬7. Melatonin CR
| [2] MTNR1A MTNR1A,MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 202 202 💬7. Melatonin CR
| ||||||||||||||||||||||||||||||
8 | RM-493 | - | - | - | - | [2] 193 193, 202 💬
| ||||||||||||||||||||||||||||||
9 | Setmelanotide | [1] Setmelanotide Setmelanotide | [1] Setmelanotide
Setmelanotide
💬9. Setmelanotide
| [1] MC4R MC4R 💬9. Setmelanotide
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 202 202, 265 💬
| ||||||||||||||||||||||||||||||
10 | Tasimelteon | [1] Tasimelteon Tasimelteon | [1] Tasimelteon
Tasimelteon
💬10. Tasimelteon
| [2] MTNR1A MTNR1A,MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [1] 202 202 💬10. Tasimelteon
|